Scientists track experimental breast cancer pill through the body
NCT ID NCT04940026
Summary
This early-stage study aimed to understand how the body absorbs, breaks down, and eliminates an experimental oral drug called SAR439859, which is being developed for breast cancer. Six healthy post-menopausal women received a single, very small dose containing a safe radioactive tracer, allowing researchers to track the drug's journey. The main goal was to gather basic information about how the drug moves through the body, not to test its effectiveness against cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number 8260001
Nottingham, NG11 6JS, United Kingdom
Conditions
Explore the condition pages connected to this study.